Rare diseases
Investigational molecules
Locations
Back to Bulgaria176 clinical trials in Varna, Bulgaria across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on the Effectiveness and Safety of Oxymetazoline Hydrochloride Eye Drops for Adults with Acquired Blepharoptosis
BulgariaStudy on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)
BulgariaStudy on Vafidemstat for Treating Negative Symptoms and Cognitive Impairment in Adults with Schizophrenia
BulgariaEfficacy, Safety, and Tolerability of NBI-1065890 in Adults with Tardive Dyskinesia
BulgariaStudy of belumosudil versus drug combination in patients aged 12 years and older with chronic graft‑versus‑host disease refractory after prior therapy
BulgariaStudy of Camoteskimab and Sodium Chloride Placebo in Adults with Moderate-to-Severe Atopic Dermatitis
BulgariaPhase 3 Randomized Placebo‑Controlled Study of Efgartigimod Alfa in Adults with Graves’ Disease Inadequately Controlled by Antithyroid Drugs
BulgariaEfficacy and Safety of JNJ-78934804 (guselkumab and golimumab) in Adults with Moderately to Severely Active Ulcerative Colitis
BulgariaRandomized trial of elecoglipron with dapagliflozin versus placebo in adults with type 2 diabetes mellitus and impaired renal function
BulgariaEffect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)
BulgariaEfficacy and Safety of Depemokimab for Early Intervention in Adults and Adolescents with Type 2 Asthma at Risk of Exacerbations
BulgariaRemibrutinib in Chronic Spontaneous Urticaria for Patients Who Benefited from a Previous Remibrutinib Trial
BulgariaThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on asthma management and treatments for moderate to severe cases, including studies of novel antibodies and improved inhaler formulations.
Research aims to enhance breathing function and reduce exacerbations in patients with respiratory conditions.
Comprehensive studies addressing multiple sclerosis, depression, and anxiety disorders, with trials evaluating both established and experimental therapeutic approaches.
Focus on improving quality of life through innovative therapeutic interventions.
Studies targeting cardiovascular diseases and metabolic conditions, including trials for obesity management and stroke prevention.
Research aimed at reducing cardiovascular risks and improving metabolic health outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
